Stock Market Watch

Pharmasset will be acquired by GILD, Analysts review ratings on company

by ·




Pharmasset, Inc. (NASDAQ:VRUS). Last Market Price: 134.2, Change: +61.53, % Change: (84.67%). Shares trade in the range of 134.14 – 135.00 dollars. It has a market capitalization of 10.15B dollars, making it a Large Cap Stock and has 75.66M outstanding shares. The company has a beta of 0.51, indicating, the stock to be less volatile than the market. As per the most recent quarterly report, the net income per share (EPS) is -1.25; P/E of – indicating high expected future growth in earnings. It operates in Healthcare sector and belongs to Biotechnology and Drugs industry. Percentage shares held by institutional investors is 100%. The company has a 52 week Price range (low – high) of $ 20.49 – 135.00. Average volumes of shares traded daily are 1,520,000. Volume traded in the last session was at 15,600,000, 10.26 times the average volume.

  • VRUS will be acquired by GILD for $137 in cash
  • The transaction, which values Pharmasset at approximately $11 billion, was unanimously approved by Pharmasset’s Board of Directors.
  • Robert W. Baird Analysts reiterate a Positive Rating on Pharmasset
  • Piper Jaffray has downgraded the company from Overweight to Neutral after the announcement

For Q3 (Sep ’11), It had a Net profit margin of -16063.69%, an Operating margin of -15984.71%. Other Key stats and ratios are : Return on average assets of -55.46%, Return on average equity of -61.19%. The organization has an employee strength of 82

Consensus Recommendation is a Outperform.


Estimate for sales for the Year Ending Sep-12 show a mean of 2.77 million dollars, an estimate high of 10.00 million dollars and an estimate low of 0.90 million dollars. A year ago the figures stood at 11.29 million dollars.

Estimate for sales for the Year Ending Sep-13 show a mean of 10.26 million dollars, an estimate high of 35.00 million dollars and an estimate low of 0.00 million dollars. A year ago the figures stood at 27.29 million dollars.

Estimate for EPS for the Year Ending Sep-12 show a mean of -1.82 dollars, an estimate high of -1.17 dollars and an estimate low of -5.20 dollars. A year ago the figures stood at -1.00 dollars.

Estimate for EPS for the Year Ending Sep-13 show a mean of -2.17 dollars, an estimate high of -1.23 dollars and an estimate low of -6.28 dollars. A year ago the figures stood at -0.86 dollars.

Sales for Quarter Ending Sep-11 was estimated at 2.24 million dollars, however the actual sales figure stood at 0.16 million dollars, 2.09 million dollars less than estimates.

Sales for Quarter Ending Jun-11 was estimated at 3.35 million dollars, however the actual sales figure stood at 0.25 million dollars, 3.1 million dollars less than estimates.

More Posts by this author

edliston
Post Written By: Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing in his yacht.


Tags:

Ed Liston

Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications. He is widely quoted in various financial publications on the Internet. When Ed is not writing about stocks, investing in stocks, talking about stocks, or otherwise doing something stock related, he likes to go sailing and fishing.

You may also like...